A Study to Evaluate the Efficacy and Safety of HRS-4729 Injection in Obesity

NCT07690826 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: HRS-4729 Injection
DRUG: HRS-4729 Injection
DRUG: HRS-4729 Injection
DRUG: HRS-4729 Injection;
DRUG: HRS-4729 Injection;
DRUG: HRS-4729 Injection;
DRUG: HRS-4729 Injection Placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.